Results 11 to 20 of about 2,332,572 (294)

Epileptic spasms: Evidence for oral corticosteroids and implications for low and middle income countries

Seizure: the Journal of the British Epilepsy Association, 2018
Implementation of international guidelines for the treatment of epileptic spasms, is challenging when access to adrenocorticotrophic hormone (ACTH) and vigabatrin is restricted, especially in Low and Middle Income Countries (LMIC).
Jo Wilmshurst
exaly   +2 more sources

Corticosteroid in various Oral lesions

Update Dental College Journal, 2016
Corticosteroids, since their introduction have become one of the most widely prescribed class of drugs. They belong to a class of chemicals that includes steroid hormones that are produced naturally in the adrenal cortex of vertebrates and analogous to ...
Md Ashif Iqbal, SM Abdul Quader, Jesmin Mohol, Sudeshna Priyadarshini Das Gupta   +3 more
doaj   +3 more sources

An update on the efficacy of oral corticosteroids in the treatment of wheezing episodes in preschool children

Therapeutic Advances in Respiratory Disease, 2014
Traditionally, oral corticosteroids (OCSs) have been the mainstay of treatment for acute wheezing episodes among preschool children with a history of recurrent wheezing.
Avraham Beigelman
exaly   +2 more sources

Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing?

Journal of Allergy and Clinical Immunology, 2013
Background Oral corticosteroids (OCSs) are recommended for severe wheezing episodes in children. However, limited evidence supports this intervention in preschool children with outpatient wheezing illnesses.
Robert Zeiger, Avraham Beigelman, Katherine Rivera-Spoljaric   +2 more
exaly   +2 more sources

Oral Corticosteroids Tapering in Severe Asthma [PDF]

American Journal of Respiratory and Critical Care Medicine, 2021
Louis-Philippe Boulet, Krystelle Godbout
openaire   +3 more sources

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

European Archives of Oto-Rhino-Laryngology, 2021
Purpose As the COVID-19 pandemic continues, an increasing number of patients are afflicted by olfactory loss, a now well-recognized symptom of the disease.
S. L. Le Bon, D. Konopnicki, Nathalie Pisarski, L. Prunier, Jérôme R. Lechien, M. Horoi   +5 more
semanticscholar   +1 more source

Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand

Respirology (Carlton South. Print), 2021
Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is highly effective for both acute and chronic diseases, but evidence indicates that indiscriminate OCS use is common, posing a risk of serious side effects and ...
J. Blakey, L. Chung, V. McDonald, L. Ruane, J. Gornall, C. Barton, S. Bosnic‐Anticevich, J. Harrington, M. Hew, A. Holland, Trudy Hopkins, L. Jayaram, H. Reddel, J. Upham, P. Gibson, P. Bardin   +15 more
semanticscholar   +1 more source

Systemic corticosteroids in treatment of chronic rhinosinusitis—A systematic review

European Clinical Respiratory Journal, 2023
Purpose When first-line chronic rhinosinusitis (CRS) treatment fails, patients can either be treated with oral or injected systemic corticosteroids. Although the EPOS and international guidelines for CRS do not mention injected corticosteroids, it is ...
Sarah Tamene, Kim Dalhoff, Peter Schwarz, Vibeke Backer, Kasper Aanaes   +4 more
doaj   +1 more source

Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids

Journal of Crohn's and Colitis, 2014
Jordi Guardiola, Eugeni Domenech, Esther Garcia Planella   +2 more
exaly   +2 more sources

Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality

European Respiratory Journal, 2022
Background Long-term oral corticosteroid (OCS) treatment for severe asthma is known to cause significant adverse effects, but knowledge on effects of lower exposures in general asthma populations is limited.
I. Skov, Hanne Madsen, D. Henriksen, J. H. Andersen, A. Pottegård, J. Davidsen   +5 more
semanticscholar   +1 more source